TURTLE CAMERON (Chief Executive Officer) sold 2.6% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.43M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 8/6/2026ACC: 0001636282-26-000099
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.43M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
15K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−800.00
Price / share
$93.97
Trade value
$75.18K
% of position
0.1%
8/3/2026
582.54K→581.74K
Common Stock
Direct
Shares
−7.16K
Price / share
$95.10
Trade value
$680.63K
% of position
1.2%
8/3/2026
581.74K→574.58K
Common Stock
Direct
Shares
−5.63K
Price / share
$95.93
Trade value
$540.57K
% of position
1.0%
8/3/2026
574.58K→568.95K
Common Stock
Direct
Shares
−1.39K
Price / share
$96.82
Trade value
$134.77K
% of position
0.2%
8/3/2026
568.95K→567.56K
Common Stock
Direct
Shares
−16.00
Price / share
$97.46
Trade value
$1.56K
% of position
0.0%
8/3/2026
567.56K→567.54K
Total
Net shares
−15K
Net value
-$1.43M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −800.00 | $93.97 | $75.18K | 0.1% | 582.54K | 581.74K |
| Common Stock Direct | 8/3/2026 | S · Sale | −7.16K | $95.10 | $680.63K | 1.2% | 581.74K | 574.58K |
| Common Stock Direct | 8/3/2026 | S · Sale | −5.63K | $95.93 | $540.57K | 1.0% | 574.58K | 568.95K |
| Common Stock Direct | 8/3/2026 | S · Sale | −1.39K | $96.82 | $134.77K | 0.2% | 568.95K | 567.56K |
| Common Stock Direct | 8/3/2026 | S · Sale | −16.00 | $97.46 | $1.56K | 0.0% | 567.56K | 567.54K |
| Total | −15K | -$1.43M | ||||||
Derivative Transactions0
No derivative transactions reported